Community Pharmacy Locally Commissioned Service for Emergency Palliative Care Drugs

Description

NHS Sussex Integrated Care Board (ICB) has recommissioned the Community Pharmacy Locally Commissioned Service for Emergency Palliative Care Drugs to support people with palliative and end of life care needs access to medication in an emergency. Lot 1: This is a Provider Selection Regime (PSR) Intention to Award Notice following the conclusion of a Competitive Process to appoint providers to deliver the Community Pharmacy Emergency Palliative Care Drugs Locally Commissioned Service on behalf of NHS Sussex Integrated Care Board (ICB), subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or the Procurement Act 2023 do not apply to this award. The publication of this notice marks the commencement of the standstill period. Any representations in relation to this notice must be made to decisions makers by midnight on 30/10/2025. Any written representations should be sent to robert.kitt1@nhs.net. This contract has not yet formally been awarded; this notice serves as an Intention to Award Notice under PSR 2023, to inform the market of the intention to award a contract, as a result of a Competitive Process. NHS Sussex Integrated Care Board (ICB) has recommissioned the Community Pharmacy Locally Commissioned Service for Emergency Palliative Care Drugs to support people with palliative and end of life care needs access to medication in an emergency. The ICB is seeking providers to hold a locally agreed range and minimum quantity of emergency palliative care drugs (based on the Sussex palliative and end of life care prescribing guidance) with a commitment to ensure that users of this service have prompt access to these medicines during the pharmacy's regular core and supplementary hours. NHS Sussex ICB intends to award the contract to 72 pharmacies within East Sussex, West Sussex and Brighton and Hove following a Competitive Process. The approximate lifetime value of the contract across the 29-month period from 1 November 2025 - 31 March 2028 will be £190,513.